Drug Type Oncolytic virus |
Synonyms G47Δ mIL2, G47ΔmIL2 |
Target |
Mechanism IL-2R modulators(Interleukin-2 receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Preclinical | US | 09 Apr 2024 | |
Glioblastoma | Preclinical | US | 09 Apr 2024 |